The AIDA consortium is a European Consortium funded by the Seventh Framework Program of the EU to run three randomized clinical trials in different infectious diseases aiming to prove that old and cheap antimicrobials remain equally active to newer and more expensive antimicrobials. The Work Package 2 of the AIDA was run by the HISS through collaboration with Micron Research Ltd.
Study title: “A prospective, open label, randomized controlled clinical trial, with pharmacokinetic-pharmacodynamic validation, to compare antimicrobial treatment with oral minocycline plus rifampicin to treatment with oral linezolid for complicated skin and skin structure infections (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA)”.
EudraCT number: 2014-001276-56
National Organization for Medicines Approval: IS-83/14
National Ethics Committee Approval: 87/14
Duration: November 2014 and December 2016
Study phase: IV
Number of Study sites: 17
Total number of enrolled patients: 122